Second-Line Combination Therapies in Pancreatic Cancer: Where Are We Now?

被引：4
|
作者：
Uccello, Mario [1 ]
Moschetta, Michele [1 ]
Arkenau, Hendrik-Tobias [1 ]
机构：
[1] Sarah Cannon Res Inst UK, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 12期
关键词：
PACLITAXEL PLUS GEMCITABINE; TRIAL;
D O I：
10.1200/JCO.2016.71.0921
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1370 / +
页数：3
相关论文
共 50 条
  • [31] Second-line therapies in immune thrombocytopenia
    Grace, Rachael F.
    Neunert, Cindy
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 698 - 706
  • [32] Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer
    Roviello, Giandomenico
    Aprile, Giuseppe
    Catalano, Martina
    Ramello, Monica
    Conca, Raffaele
    Petrioli, Roberto
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (15) : 1788 - 1791
  • [33] Gemcitabine-resistant pancreatic cancer: a second-line option
    Oettle, Helmut
    Lehmann, Thorsten
    LANCET, 2016, 387 (10018): : 507 - 508
  • [34] Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
    Seong Yoon Yi
    Young Suk Park
    Hyo Song Kim
    Hyun Jung Jun
    Kyoung Ha Kim
    Myung Hee Chang
    Min Jae Park
    Ji Eun Uhm
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Jong Kyun Lee
    Kyu Taek Lee
    Ho Yeong Lim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 1141 - 1145
  • [35] Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
    Park, Y.
    Yi, S.
    Kim, H.
    Lee, S.
    Hwang, I.
    Park, S.
    Park, B.
    Park, J.
    Lim, H.
    Kang, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
    Yi, Seong Yoon
    Park, Young Suk
    Kim, Hyo Song
    Jun, Hyun Jung
    Kim, Kyoung Ha
    Chang, Myung Hee
    Park, Min Jae
    Uhm, Ji Eun
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1141 - 1145
  • [37] Beneficial trends of second-line chemotherapy in advanced pancreatic cancer
    Silva, Milton Jose B.
    Maia, Joyce Maria L.
    Ribeiro, Adriana Regina G.
    Chinen, Ludmilla T. D.
    Paiva, Tadeu Ferreira, Jr.
    Padua, Fernando Vidigal
    Ismael Pinto, Flavio Augusto
    Santos, Elizabeth Santana
    Mello, Celso Lopes
    Campanha, Daniel
    Rodrigues Pereira, Augusto Akikubo
    Fanelli, Marcello Ferretti
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
    Balsano, Rita
    Tommasi, Chiara
    Garajova, Ingrid
    ANTICANCER RESEARCH, 2019, 39 (07) : 3405 - 3412
  • [39] Targeting replication stress in pancreatic cancer: A phase II trial investigating azenosertib in combination with gemcitabine in second-line advanced pancreatic cancer
    Huffman, Brandon
    Horick, Nora K.
    Bird, Alexandra
    Gibson, Caroline
    Brais, Lauren K.
    Graham, Christopher
    Schlechter, Benjamin L.
    Wolpin, Brian M.
    Aguirre, Andrew
    D'Andrea, Alan D.
    Shapiro, Geoffrey Ira
    Cleary, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Combination of second-line antirheumatic drugs
    Haagsma, CJ
    Riel, PLCM
    ANNALS OF MEDICINE, 1997, 29 (02) : 169 - 173
12345